全文获取类型
收费全文 | 11479篇 |
免费 | 920篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 103篇 |
儿科学 | 450篇 |
妇产科学 | 325篇 |
基础医学 | 1746篇 |
口腔科学 | 149篇 |
临床医学 | 1375篇 |
内科学 | 2257篇 |
皮肤病学 | 329篇 |
神经病学 | 1346篇 |
特种医学 | 143篇 |
外科学 | 1054篇 |
综合类 | 123篇 |
一般理论 | 15篇 |
预防医学 | 1412篇 |
眼科学 | 81篇 |
药学 | 712篇 |
中国医学 | 18篇 |
肿瘤学 | 789篇 |
出版年
2023年 | 60篇 |
2022年 | 98篇 |
2021年 | 277篇 |
2020年 | 176篇 |
2019年 | 282篇 |
2018年 | 289篇 |
2017年 | 215篇 |
2016年 | 240篇 |
2015年 | 273篇 |
2014年 | 370篇 |
2013年 | 538篇 |
2012年 | 822篇 |
2011年 | 803篇 |
2010年 | 450篇 |
2009年 | 348篇 |
2008年 | 629篇 |
2007年 | 731篇 |
2006年 | 681篇 |
2005年 | 667篇 |
2004年 | 594篇 |
2003年 | 591篇 |
2002年 | 525篇 |
2001年 | 181篇 |
2000年 | 142篇 |
1999年 | 156篇 |
1998年 | 142篇 |
1997年 | 113篇 |
1996年 | 126篇 |
1995年 | 85篇 |
1994年 | 78篇 |
1993年 | 97篇 |
1992年 | 120篇 |
1991年 | 100篇 |
1990年 | 111篇 |
1989年 | 98篇 |
1988年 | 89篇 |
1987年 | 81篇 |
1986年 | 66篇 |
1985年 | 72篇 |
1984年 | 65篇 |
1983年 | 42篇 |
1982年 | 61篇 |
1981年 | 71篇 |
1980年 | 42篇 |
1979年 | 59篇 |
1978年 | 56篇 |
1974年 | 48篇 |
1973年 | 44篇 |
1972年 | 38篇 |
1970年 | 39篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Rizzo Manglio Miguel Bluthgen Mara Virginia Recondo Gonzalo Naveira Martin Perfetti Aldo Rizzi Florencia Kuzminin Alejandro Faura Victoria Cerini Matas Videla Alejandro Silva Carlos Lupinacci Lorena Minatta Nicols 《International journal of clinical oncology / Japan Society of Clinical Oncology》2021,26(6):1057-1064
International Journal of Clinical Oncology - Immune-checkpoint inhibitors (ICIs) are standard treatments for metastatic non-small cell lung cancer (NSCLC). Patients with poor performance status... 相似文献
2.
Caroline E. Sloan Judy Zhong Dinushika Mohottige Rasheeda Hall Clarissa J. Diamantidis Leight E. Boulware Virginia Wang 《Seminars in dialysis》2020,33(6):440-448
Caring for patients with end-stage kidney disease (ESKD) in the United States is challenging, due in part to the complex epidemiology of the disease's progression as well as the ways in which care is delivered. As CKD progresses toward ESKD, the number of comorbidities increases and care involves multiple healthcare providers from multiple subspecialties. This occurs in the context of a fragmented US healthcare delivery system that is traditionally siloed by provider specialty, organization, as well as systems of payment and administration. This article describes the role of care fragmentation in the delivery of optimal ESKD care and identifies research gaps in the evidence across the continuum of care. We then consider the impact of care fragmentation on ESKD care from the patient and health system perspectives and explore opportunities for system-level interventions aimed at improving care for patients with ESKD. 相似文献
3.
Dalton Luiz Schiessel Ricardo K. Yamazaki Marcelo Kryczyk Isabela Coelho de Castro Adriana A. Yamaguchi Danielle C. T. Pequito 《Nutrition and cancer》2016,68(8):1369-1380
Objective: Polyunsaturated fatty acids n-3 (PUFA n-3) have shown effects in reducing tumor growth, in particular eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) abundantly present in fish oil (FO). When these fatty acids are provided in the diet, they alter the functions of the cells, particularly in tumor and immune cells. However, the effects of α-linolenic fatty acid (ALA), which is the precursor of EPA and DHA, are controversial. Thus, our objective was to test the effect of this parental fatty acid. Methods: Non-tumor-bearing and tumor-bearing Wistar rats (70 days) were supplemented with 1 g/kg body weight of FO or Oro Inca® (OI) oil (rich in ALA). Immune cells function, proliferation, cytokine production, and subpopulation profile were evaluated. Results: We have shown that innate immune cells enhanced phagocytosis capacity, and increased processing and elimination of antigens. Moreover, there was a decrease in production of pro-inflammatory cytokines (tumor necrosis factor-alpha (TNF-α) and interleukin 6 (IL-6)) by macrophages. Lymphocytes showed decreased proliferation capacity, increased cluster of differentiation 8 (CD8+) subpopulation, and increased TNF-α production. Conclusions: Oil rich in ALA caused similar immune modulation in cancer when compared with FO. 相似文献
4.
5.
6.
W. Dalton Dietrich 《Topics in spinal cord injury rehabilitation》2015,21(2):174-187
It was an honor for me to present the 2014 G. Heiner Sell Memorial Lecture at the annual American Spinal Injury Association (ASIA) meeting in San Antonio. For this purpose, I provided a comprehensive review of the scope of research targeting discovery and translational and clinical investigations into spinal cord injury (SCI) research. Indeed, these are exciting times in the area of spinal cord research and clinical initiatives. Many laboratories and clinical programs throughout the world are publishing data related to the pathophysiology of SCI and new strategies for protecting and promoting recovery in both animal models and humans. For this lecture, several topics were discussed including neuroprotective and reparative strategies, neurorehabilitation, quality of life issues, and future directions. In the area of neuroprotection, pathophysiological events that may be targeted with therapeutic strategies, including pharmacological and targeted temperature management were reviewed. For reparative approaches, the importance of both intrinsic and extrinsic mechanisms of axonal regeneration was highlighted. Various cell therapies currently being tested in preclinical and clinical arenas were reviewed as well as ongoing US Food and Drug Administration approved trials for SCI patients. Neurorehabilitation is an evolving research field with locomotive training strategies, electrical stimulation, and brain-machine interface programs targeting various types of SCI. The importance of testing combination approaches including neuroprotective, reparative, and rehabilitative strategies to maximize recovery mechanisms was therefore emphasized. Finally, quality of life issues that affect thousands of individuals living with paralysis were also presented. Future directions and specific obstacles that require attention as we continue to move the SCI field forward were discussed. 相似文献
7.
8.
9.
Bernard P Halloran Virginia L Ferguson Steven J Simske Andrew Burghardt Laura L Venton Sharmila Majumdar 《Journal of bone and mineral research》2002,17(6):1044-1050
To determine whether the mouse loses bone with aging and whether the changes mimic those observed in human aging, we examined the changes in the tibial metaphysis and diaphysis in the male C57BL/6J mouse over its life span using microcomputed tomography (microCT). Cancellous bone volume fraction (BV/TV) decreased 60% between 6 weeks and 24 months of age. Loss was characterized by decreased trabecular number (Tb.N), increased trabecular spacing (Tb.Sp), and decreased connectivity. Anisotropy decreased while the structure model index increased with age. Cortical bone thickness increased between 6 weeks and 6 months of age and then decreased continuously to 24 months (-12%). Cortical bone area (Ct.Ar) remained constant between 6 and 24 months. Fat-free weight reached a peak at 12 months and gradually declined to 24 months. Total mass lost between 12 and 24 months reached 10%. Overall, the age-related changes in skeletal mass and architecture in the mouse were remarkably similar to those seen in human aging. Furthermore, the rapid early loss of cancellous bone suggests that bone loss is not just associated with old age in the mouse but rather occurs as a continuum from early growth. We conclude that the C57BL/6J male mouse maybe a useful model to study at least some aspects of age-related bone loss in humans. 相似文献
10.